Sirolimus Coated Balloon
Sirolimus Coated Balloon is a medical device with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
The All-comers Sirolimus-coated Balloon European Registry
Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon
Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon
Sirolimus Coated Angioplasty Versus Plain Balloon Angioplasty
Clinical Trials (6)
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
The All-comers Sirolimus-coated Balloon European Registry
Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon
Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon
Sirolimus Coated Angioplasty Versus Plain Balloon Angioplasty
Sirolimus Coated Angioplasty Balloon in the Salvage of Thrombosed Arteriovenous Graft
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6